NumerixS Investment Technologies’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-4,200
Closed -$43K 421
2020
Q2
$43K Buy
4,200
+2,491
+146% +$25.5K 0.01% 821
2020
Q1
$17K Sell
1,709
-17,091
-91% -$201K 0.01% 825
2019
Q4
$250K Sell
18,800
-8,035
-30% -$88.6K 0.05% 422
2019
Q3
$230K Buy
26,835
+16,500
+160% +$160K 0.06% 347
2019
Q2
$113K Sell
10,335
-7,575
-42% -$84.9K 0.03% 568
2019
Q1
$190K Buy
+17,910
New +$200K 0.03% 682
2018
Q2
Sell
-119
Closed -$2K 1237
2018
Q1
$2K Sell
119
-9,554
-99% -$119K ﹤0.01% 1017
2017
Q4
$121K Buy
+9,673
New +$126K 0.03% 625
2017
Q3
Sell
-20,673
Closed -$327K 1244
2017
Q2
$327K Buy
+20,673
New +$300K 0.05% 465
2017
Q1
Sell
-13,373
Closed -$171K 1258
2016
Q4
$171K Buy
+13,373
New +$169K 0.02% 719
2015
Q2
Sell
-13,089
Closed -$175K 693
2015
Q1
$175K Buy
+13,089
New +$172K 0.03% 543

Other funds holding IRWD

NumerixS Investment Technologies's IRWD Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2020, closing a stake of 4,200 shares — an estimated $43K sold.

NumerixS Investment Technologies first reported a position in IRWD in Q1 2015 and held it in 11 quarters. The position peaked at $327K in Q2 2017. 190 funds tracked by Wall St. Rank hold IRWD as of Q3 2020.

  • NumerixS Investment Technologies reported no remaining Ironwood Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 4,200 Ironwood Pharmaceuticals shares in Q3 2020, an estimated $43K.
  • NumerixS Investment Technologies first reported a position in Ironwood Pharmaceuticals in Q1 2015 and held it in 11 quarters.
  • NumerixS Investment Technologies's Ironwood Pharmaceuticals position peaked at $327K in Q2 2017.
  • 190 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.